Definitive chemoradiotherapy for advanced pulmonary sarcomatoid carcinoma

Kazuya Takeda, Haruo Matsushita, Masaki Kubozono, Takaya Tanabe, Yojiro Ishikawa, Takaya Yamamoto, Maiko Kozumi, Noriyoshi Takahashi, Yu Katagiri, Shun Tasaka, Katsuya Fukui, Ken Takeda, Fumiyoshi Fujishima, Masakazu Ichinose, Keiichi Jingu

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)

Abstract

Pulmonary sarcomatoid carcinoma is a rare subtype of non-small cell lung cancer with a poor prognosis. We herein report on a case of pulmonary sarcomatoid carcinoma that was treated successfully by concurrent chemoradiotherapy. A 65-year-old man was diagnosed to have pulmonary pleomorphic carcinoma (clinical T4N2M0 stage IIIB). He received concurrent chemoradiotherapy (60 Gy of radiotherapy in 30 fractionations and two courses of chemotherapy with carboplatin and paclitaxel). After chemoradiotherapy, a significant reduction of the tumor size was observed. Two courses of adjuvant chemotherapy were performed. He is currently alive at 15 months after the first treatment without any recurrence or metastasis.

Original languageEnglish
Pages (from-to)3325-3330
Number of pages6
JournalInternal Medicine
Volume55
Issue number22
DOIs
Publication statusPublished - 2016

Keywords

  • Chemoradiotherapy
  • Pulmonary sarcomatoid carcinoma

ASJC Scopus subject areas

  • Internal Medicine

Fingerprint Dive into the research topics of 'Definitive chemoradiotherapy for advanced pulmonary sarcomatoid carcinoma'. Together they form a unique fingerprint.

Cite this